Md. hospital NICU reopens after investigation of Pseudomonas bacteria

The hospital invested more than $500,000 in a new water-treatment system


The neonatal intensive-care unit (NICU) at Prince George’s Hospital Center in Cheverly, Md., has reopened four months after an investigation of an outbreak of a potentially deadly bacteria, according to an article on The Washington Post website.

The unit was cleared after the Centers for Disease Control and Prevention reaffirmed that the bacteria originated in the plumbing and the hospital completed significant improvements to that system.

The hospital invested more than $500,000 in a new water-treatment system to clean and regularly flush its pipes. 

It also has implemented more-rigid protocols and oversight of ­infection-control procedures for hand washing, bacteria surveillance and water testing, the article said.

Read the article.

 

 



April 13, 2017


Topic Area: Infection Control


Recent Posts

How Architects Shape the Future of Healthcare Facilities

Healthcare architecture is more than just designing and building hospitals.


UNC Health, Duke Health Form Partnership for Stand-alone Children's Hospital

The partners plan to break ground together on the new NC Children’s campus by 2027.


Sarasota Memorial Hospital Plans to Build New Facility in North Port

The six-story, 100-bed hospital is slated to open in fall of 2028.


CMMS, Data and the Path to Compliance

Taking control of healthcare facilities data in CMMS enables managers to use it to ensure the efficient operation and maintenance of their assets.


Healthcare is a Major Ransomware Target

Healthcare is the third-most-targeted sector, according to the report.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.